aluates Reports

$ 0.0

Automative

Global Acne Vulgaris Treatment Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-17Z6292

Global Acne Vulgaris Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Acne Vulgaris Treatment Market Research Report 2025

Code: QYRE-Auto-17Z6292

Report

January 2025

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Common Pharma Inc

Cutanea Life Sciences Inc

Dermira

Elorac

Ensol Biosciences Inc

Foamix Pharmaceuticals Ltd

Galderma SA

GlaxoSmithKline PLC

Helix BioMedix Inc

Hovione FarmaCiencia SA

Lee's Pharmaceutical Holdings Ltd

LEO Pharma A/S

NovaBiotics Ltd

Novan

Novartis

Paratek Pharmaceuticals Inc.

Pfizer Inc

Phosphagenics Limited

Acne Vulgaris Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Acne Vulgaris Treatment Market

The global market for Acne Vulgaris Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Acne Vulgaris Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acne Vulgaris Treatment.

The Acne Vulgaris Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acne Vulgaris Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acne Vulgaris Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Acne Vulgaris Treatment Market Report

Report Metric	Details
Report Name	Acne Vulgaris Treatment Market
CAGR	5%
Segment by Type	CB-0601 CJM-112 CLS-007 Dapsone DFD-10 DLX-2323 Others
Segment by Application	Clinic Hospital Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc, ELORAC Inc, Ensol Biosciences Inc, Foamix Pharmaceuticals Ltd, Galderma SA, GlaxoSmithKline Plc, Helix BioMedix Inc, Hovione FarmaCiencia SA, Lee's Pharmaceutical Holdings Ltd, LEO Pharma A/S, Novabiotics Ltd, Novan Inc, Novartis AG, Paratek Pharmaceuticals Inc, Pfizer Inc, Phosphagenics Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acne Vulgaris Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Acne Vulgaris Treatment Market report?

Ans: The main players in the Acne Vulgaris Treatment Market are Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc, ELORAC Inc, Ensol Biosciences Inc, Foamix Pharmaceuticals Ltd, Galderma SA, GlaxoSmithKline Plc, Helix BioMedix Inc, Hovione FarmaCiencia SA, Lee's Pharmaceutical Holdings Ltd, LEO Pharma A/S, Novabiotics Ltd, Novan Inc, Novartis AG, Paratek Pharmaceuticals Inc, Pfizer Inc, Phosphagenics Ltd

What are the Application segmentation covered in the Acne Vulgaris Treatment Market report?

Ans: The Applications covered in the Acne Vulgaris Treatment Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Acne Vulgaris Treatment Market report?

Ans: The Types covered in the Acne Vulgaris Treatment Market report are CB-0601, CJM-112, CLS-007, Dapsone, DFD-10, DLX-2323, Others

Recommended Reports

Dermatological Treatments

Inflammatory Diseases

Acne and Related

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acne Vulgaris Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CB-0601

1.2.3 CJM-112

1.2.4 CLS-007

1.2.5 Dapsone

1.2.6 DFD-10

1.2.7 DLX-2323

1.2.8 Others

1.3 Market by Application

1.3.1 Global Acne Vulgaris Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acne Vulgaris Treatment Market Perspective (2020-2031)

2.2 Global Acne Vulgaris Treatment Growth Trends by Region

2.2.1 Global Acne Vulgaris Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Acne Vulgaris Treatment Historic Market Size by Region (2020-2025)

2.2.3 Acne Vulgaris Treatment Forecasted Market Size by Region (2026-2031)

2.3 Acne Vulgaris Treatment Market Dynamics

2.3.1 Acne Vulgaris Treatment Industry Trends

2.3.2 Acne Vulgaris Treatment Market Drivers

2.3.3 Acne Vulgaris Treatment Market Challenges

2.3.4 Acne Vulgaris Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Acne Vulgaris Treatment Players by Revenue

3.1.1 Global Top Acne Vulgaris Treatment Players by Revenue (2020-2025)

3.1.2 Global Acne Vulgaris Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Acne Vulgaris Treatment Revenue

3.4 Global Acne Vulgaris Treatment Market Concentration Ratio

3.4.1 Global Acne Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Treatment Revenue in 2024

3.5 Global Key Players of Acne Vulgaris Treatment Head office and Area Served

3.6 Global Key Players of Acne Vulgaris Treatment, Product and Application

3.7 Global Key Players of Acne Vulgaris Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Acne Vulgaris Treatment Breakdown Data by Type

4.1 Global Acne Vulgaris Treatment Historic Market Size by Type (2020-2025)

4.2 Global Acne Vulgaris Treatment Forecasted Market Size by Type (2026-2031)

5 Acne Vulgaris Treatment Breakdown Data by Application

5.1 Global Acne Vulgaris Treatment Historic Market Size by Application (2020-2025)

5.2 Global Acne Vulgaris Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Acne Vulgaris Treatment Market Size (2020-2031)

6.2 North America Acne Vulgaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Acne Vulgaris Treatment Market Size by Country (2020-2025)

6.4 North America Acne Vulgaris Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Acne Vulgaris Treatment Market Size (2020-2031)

7.2 Europe Acne Vulgaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Acne Vulgaris Treatment Market Size by Country (2020-2025)

7.4 Europe Acne Vulgaris Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Acne Vulgaris Treatment Market Size (2020-2031)

8.2 Asia-Pacific Acne Vulgaris Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Acne Vulgaris Treatment Market Size (2020-2031)

9.2 Latin America Acne Vulgaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Acne Vulgaris Treatment Market Size by Country (2020-2025)

9.4 Latin America Acne Vulgaris Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Acne Vulgaris Treatment Market Size (2020-2031)

10.2 Middle East & Africa Acne Vulgaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Common Pharma Inc

11.1.1 Common Pharma Inc Company Details

11.1.2 Common Pharma Inc Business Overview

11.1.3 Common Pharma Inc Acne Vulgaris Treatment Introduction

11.1.4 Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.1.5 Common Pharma Inc Recent Development

11.2 Cutanea Life Sciences Inc

11.2.1 Cutanea Life Sciences Inc Company Details

11.2.2 Cutanea Life Sciences Inc Business Overview

11.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Introduction

11.2.4 Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.2.5 Cutanea Life Sciences Inc Recent Development

11.3 Dermira Inc

11.3.1 Dermira Inc Company Details

11.3.2 Dermira Inc Business Overview

11.3.3 Dermira Inc Acne Vulgaris Treatment Introduction

11.3.4 Dermira Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.3.5 Dermira Inc Recent Development

11.4 ELORAC Inc

11.4.1 ELORAC Inc Company Details

11.4.2 ELORAC Inc Business Overview

11.4.3 ELORAC Inc Acne Vulgaris Treatment Introduction

11.4.4 ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.4.5 ELORAC Inc Recent Development

11.5 Ensol Biosciences Inc

11.5.1 Ensol Biosciences Inc Company Details

11.5.2 Ensol Biosciences Inc Business Overview

11.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Introduction

11.5.4 Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.5.5 Ensol Biosciences Inc Recent Development

11.6 Foamix Pharmaceuticals Ltd

11.6.1 Foamix Pharmaceuticals Ltd Company Details

11.6.2 Foamix Pharmaceuticals Ltd Business Overview

11.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Introduction

11.6.4 Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.6.5 Foamix Pharmaceuticals Ltd Recent Development

11.7 Galderma SA

11.7.1 Galderma SA Company Details

11.7.2 Galderma SA Business Overview

11.7.3 Galderma SA Acne Vulgaris Treatment Introduction

11.7.4 Galderma SA Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.7.5 Galderma SA Recent Development

11.8 GlaxoSmithKline Plc

11.8.1 GlaxoSmithKline Plc Company Details

11.8.2 GlaxoSmithKline Plc Business Overview

11.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Introduction

11.8.4 GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.8.5 GlaxoSmithKline Plc Recent Development

11.9 Helix BioMedix Inc

11.9.1 Helix BioMedix Inc Company Details

11.9.2 Helix BioMedix Inc Business Overview

11.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Introduction

11.9.4 Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.9.5 Helix BioMedix Inc Recent Development

11.10 Hovione FarmaCiencia SA

11.10.1 Hovione FarmaCiencia SA Company Details

11.10.2 Hovione FarmaCiencia SA Business Overview

11.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Introduction

11.10.4 Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.10.5 Hovione FarmaCiencia SA Recent Development

11.11 Lee's Pharmaceutical Holdings Ltd

11.11.1 Lee's Pharmaceutical Holdings Ltd Company Details

11.11.2 Lee's Pharmaceutical Holdings Ltd Business Overview

11.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Introduction

11.11.4 Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.11.5 Lee's Pharmaceutical Holdings Ltd Recent Development

11.12 LEO Pharma A/S

11.12.1 LEO Pharma A/S Company Details

11.12.2 LEO Pharma A/S Business Overview

11.12.3 LEO Pharma A/S Acne Vulgaris Treatment Introduction

11.12.4 LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.12.5 LEO Pharma A/S Recent Development

11.13 Novabiotics Ltd

11.13.1 Novabiotics Ltd Company Details

11.13.2 Novabiotics Ltd Business Overview

11.13.3 Novabiotics Ltd Acne Vulgaris Treatment Introduction

11.13.4 Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.13.5 Novabiotics Ltd Recent Development

11.14 Novan Inc

11.14.1 Novan Inc Company Details

11.14.2 Novan Inc Business Overview

11.14.3 Novan Inc Acne Vulgaris Treatment Introduction

11.14.4 Novan Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.14.5 Novan Inc Recent Development

11.15 Novartis AG

11.15.1 Novartis AG Company Details

11.15.2 Novartis AG Business Overview

11.15.3 Novartis AG Acne Vulgaris Treatment Introduction

11.15.4 Novartis AG Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.15.5 Novartis AG Recent Development

11.16 Paratek Pharmaceuticals Inc

11.16.1 Paratek Pharmaceuticals Inc Company Details

11.16.2 Paratek Pharmaceuticals Inc Business Overview

11.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Introduction

11.16.4 Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.16.5 Paratek Pharmaceuticals Inc Recent Development

11.17 Pfizer Inc

11.17.1 Pfizer Inc Company Details

11.17.2 Pfizer Inc Business Overview

11.17.3 Pfizer Inc Acne Vulgaris Treatment Introduction

11.17.4 Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.17.5 Pfizer Inc Recent Development

11.18 Phosphagenics Ltd

11.18.1 Phosphagenics Ltd Company Details

11.18.2 Phosphagenics Ltd Business Overview

11.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Introduction

11.18.4 Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025)

11.18.5 Phosphagenics Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Common Pharma Inc

Cutanea Life Sciences Inc

Dermira

Elorac

Ensol Biosciences Inc

Foamix Pharmaceuticals Ltd

Galderma SA

GlaxoSmithKline PLC

Helix BioMedix Inc

Hovione FarmaCiencia SA

Lee's Pharmaceutical Holdings Ltd

LEO Pharma A/S

NovaBiotics Ltd

Novan

Novartis

Paratek Pharmaceuticals Inc.

Pfizer Inc

Phosphagenics Limited

List of Tables

Table 1. Global Acne Vulgaris Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CB-0601

Table 3. Key Players of CJM-112

Table 4. Key Players of CLS-007

Table 5. Key Players of Dapsone

Table 6. Key Players of DFD-10

Table 7. Key Players of DLX-2323

Table 8. Key Players of Others

Table 9. Global Acne Vulgaris Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Acne Vulgaris Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Acne Vulgaris Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Acne Vulgaris Treatment Market Share by Region (2020-2025)

Table 13. Global Acne Vulgaris Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Acne Vulgaris Treatment Market Share by Region (2026-2031)

Table 15. Acne Vulgaris Treatment Market Trends

Table 16. Acne Vulgaris Treatment Market Drivers

Table 17. Acne Vulgaris Treatment Market Challenges

Table 18. Acne Vulgaris Treatment Market Restraints

Table 19. Global Acne Vulgaris Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Acne Vulgaris Treatment Market Share by Players (2020-2025)

Table 21. Global Top Acne Vulgaris Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Treatment as of 2024)

Table 22. Ranking of Global Top Acne Vulgaris Treatment Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Acne Vulgaris Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Acne Vulgaris Treatment, Headquarters and Area Served

Table 25. Global Key Players of Acne Vulgaris Treatment, Product and Application

Table 26. Global Key Players of Acne Vulgaris Treatment, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Acne Vulgaris Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Acne Vulgaris Treatment Revenue Market Share by Type (2020-2025)

Table 30. Global Acne Vulgaris Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Acne Vulgaris Treatment Revenue Market Share by Type (2026-2031)

Table 32. Global Acne Vulgaris Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Acne Vulgaris Treatment Revenue Market Share by Application (2020-2025)

Table 34. Global Acne Vulgaris Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Acne Vulgaris Treatment Revenue Market Share by Application (2026-2031)

Table 36. North America Acne Vulgaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Acne Vulgaris Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Acne Vulgaris Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Acne Vulgaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Acne Vulgaris Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Acne Vulgaris Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Acne Vulgaris Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Acne Vulgaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Acne Vulgaris Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Acne Vulgaris Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Acne Vulgaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 51. Common Pharma Inc Company Details

Table 52. Common Pharma Inc Business Overview

Table 53. Common Pharma Inc Acne Vulgaris Treatment Product

Table 54. Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 55. Common Pharma Inc Recent Development

Table 56. Cutanea Life Sciences Inc Company Details

Table 57. Cutanea Life Sciences Inc Business Overview

Table 58. Cutanea Life Sciences Inc Acne Vulgaris Treatment Product

Table 59. Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 60. Cutanea Life Sciences Inc Recent Development

Table 61. Dermira Inc Company Details

Table 62. Dermira Inc Business Overview

Table 63. Dermira Inc Acne Vulgaris Treatment Product

Table 64. Dermira Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 65. Dermira Inc Recent Development

Table 66. ELORAC Inc Company Details

Table 67. ELORAC Inc Business Overview

Table 68. ELORAC Inc Acne Vulgaris Treatment Product

Table 69. ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 70. ELORAC Inc Recent Development

Table 71. Ensol Biosciences Inc Company Details

Table 72. Ensol Biosciences Inc Business Overview

Table 73. Ensol Biosciences Inc Acne Vulgaris Treatment Product

Table 74. Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 75. Ensol Biosciences Inc Recent Development

Table 76. Foamix Pharmaceuticals Ltd Company Details

Table 77. Foamix Pharmaceuticals Ltd Business Overview

Table 78. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product

Table 79. Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 80. Foamix Pharmaceuticals Ltd Recent Development

Table 81. Galderma SA Company Details

Table 82. Galderma SA Business Overview

Table 83. Galderma SA Acne Vulgaris Treatment Product

Table 84. Galderma SA Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 85. Galderma SA Recent Development

Table 86. GlaxoSmithKline Plc Company Details

Table 87. GlaxoSmithKline Plc Business Overview

Table 88. GlaxoSmithKline Plc Acne Vulgaris Treatment Product

Table 89. GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 90. GlaxoSmithKline Plc Recent Development

Table 91. Helix BioMedix Inc Company Details

Table 92. Helix BioMedix Inc Business Overview

Table 93. Helix BioMedix Inc Acne Vulgaris Treatment Product

Table 94. Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 95. Helix BioMedix Inc Recent Development

Table 96. Hovione FarmaCiencia SA Company Details

Table 97. Hovione FarmaCiencia SA Business Overview

Table 98. Hovione FarmaCiencia SA Acne Vulgaris Treatment Product

Table 99. Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 100. Hovione FarmaCiencia SA Recent Development

Table 101. Lee's Pharmaceutical Holdings Ltd Company Details

Table 102. Lee's Pharmaceutical Holdings Ltd Business Overview

Table 103. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product

Table 104. Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 105. Lee's Pharmaceutical Holdings Ltd Recent Development

Table 106. LEO Pharma A/S Company Details

Table 107. LEO Pharma A/S Business Overview

Table 108. LEO Pharma A/S Acne Vulgaris Treatment Product

Table 109. LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 110. LEO Pharma A/S Recent Development

Table 111. Novabiotics Ltd Company Details

Table 112. Novabiotics Ltd Business Overview

Table 113. Novabiotics Ltd Acne Vulgaris Treatment Product

Table 114. Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 115. Novabiotics Ltd Recent Development

Table 116. Novan Inc Company Details

Table 117. Novan Inc Business Overview

Table 118. Novan Inc Acne Vulgaris Treatment Product

Table 119. Novan Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 120. Novan Inc Recent Development

Table 121. Novartis AG Company Details

Table 122. Novartis AG Business Overview

Table 123. Novartis AG Acne Vulgaris Treatment Product

Table 124. Novartis AG Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 125. Novartis AG Recent Development

Table 126. Paratek Pharmaceuticals Inc Company Details

Table 127. Paratek Pharmaceuticals Inc Business Overview

Table 128. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product

Table 129. Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 130. Paratek Pharmaceuticals Inc Recent Development

Table 131. Pfizer Inc Company Details

Table 132. Pfizer Inc Business Overview

Table 133. Pfizer Inc Acne Vulgaris Treatment Product

Table 134. Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 135. Pfizer Inc Recent Development

Table 136. Phosphagenics Ltd Company Details

Table 137. Phosphagenics Ltd Business Overview

Table 138. Phosphagenics Ltd Acne Vulgaris Treatment Product

Table 139. Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)

Table 140. Phosphagenics Ltd Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

Table 144. Authors List of This Report

List of Figures

Figure 1. Acne Vulgaris Treatment Picture

Figure 2. Global Acne Vulgaris Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Acne Vulgaris Treatment Market Share by Type: 2024 VS 2031

Figure 4. CB-0601 Features

Figure 5. CJM-112 Features

Figure 6. CLS-007 Features

Figure 7. Dapsone Features

Figure 8. DFD-10 Features

Figure 9. DLX-2323 Features

Figure 10. Others Features

Figure 11. Global Acne Vulgaris Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Acne Vulgaris Treatment Market Share by Application: 2024 VS 2031

Figure 13. Clinic Case Studies

Figure 14. Hospital Case Studies

Figure 15. Others Case Studies

Figure 16. Acne Vulgaris Treatment Report Years Considered

Figure 17. Global Acne Vulgaris Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Acne Vulgaris Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Acne Vulgaris Treatment Market Share by Region: 2024 VS 2031

Figure 20. Global Acne Vulgaris Treatment Market Share by Players in 2024

Figure 21. Global Top Acne Vulgaris Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Treatment as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Acne Vulgaris Treatment Revenue in 2024

Figure 23. North America Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Acne Vulgaris Treatment Market Share by Country (2020-2031)

Figure 25. United States Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Acne Vulgaris Treatment Market Share by Country (2020-2031)

Figure 29. Germany Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Acne Vulgaris Treatment Market Share by Region (2020-2031)

Figure 37. China Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Acne Vulgaris Treatment Market Share by Country (2020-2031)

Figure 45. Mexico Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Acne Vulgaris Treatment Market Share by Country (2020-2031)

Figure 49. Turkey Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Common Pharma Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 53. Cutanea Life Sciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 54. Dermira Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 55. ELORAC Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 56. Ensol Biosciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 57. Foamix Pharmaceuticals Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 58. Galderma SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 59. GlaxoSmithKline Plc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 60. Helix BioMedix Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 61. Hovione FarmaCiencia SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 62. Lee's Pharmaceutical Holdings Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 63. LEO Pharma A/S Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 64. Novabiotics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 65. Novan Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 66. Novartis AG Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 67. Paratek Pharmaceuticals Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 68. Pfizer Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 69. Phosphagenics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Consumer Acne Medicine Market Research Report 2024

Topical Acne Treatment Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acne Scar Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Acne Treatment Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Acne Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cystic Acne Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Medicated Acne Patch Market Research Report 2025

Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rosacea Medicine Market Research Report 2025

Rosacea Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alopecia Treatment Market Research Report 2024

Global Vaginitis Therapeutics Market Insights Forecast to 2030

Global Still s Disease Treatment Market Research Report 2025

Drug Pharmaceuticals Cosmetics Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Eruptions Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hair Loss Growth Treatment Market Research Report 2025

Prescription Dermatological Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Sun Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37N3924

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Facial Skincare Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35H8470

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Facial Moisturizer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-25N8391

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Face Cleansing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11Q1907

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions